The race to uncloak cancer with liquid biopsies
Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete…
Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete…
The next generation of DNA sequencers has arrived, and with it, a clash of titans:…
Qiagen will acquire Spanish biotech STAT-Dx for up to €153M - more than 3 times…
Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined…
Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective…
Qiagen and Mirati will collaborate on the development of a companion diagnostic for a specific type of form…
Illumina, the €22Bn Market cap NGS specialist, and Bill Gates pooled a $100M to fund…
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor…
Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant…
Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and…
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…